Tanning lamps: Health effects and reclassification by the Food and Drug Administration - 13/12/14
Abstract |
Tanning lamps have long been considered a class I medical device under regulation by the Food and Drug Administration (FDA). A growing body of research has repeatedly documented the association between elective indoor tanning and several negative health consequences. These accepted findings have prompted action by the FDA to officially reclassify tanning lamps as a class II medical device. The main purpose of this review is to update practitioners on the current state of tanning lamp classification and highlight the practical implications of this recent change. This information can be used by clinicians to easily reference this important action, and empower patients with a better understanding of the risks associated with indoor tanning.
Le texte complet de cet article est disponible en PDF.Key words : addiction, basal cell carcinoma, Food and Drug Administration, melanoma, reclassification, squamous cell carcinoma, sunlamps, tanning beds, ultraviolet
Abbreviations used : AAD, FDA, POMC, UV
Plan
Funding sources: None. |
|
Disclosure: Dr Lim receives honoraria as a consultant for Ferndale, Uriage, Sanofi, and Johnson & Johnson. He also receives grants as an investigator for Clinuvel, Estee Lauder, and Ferndale. Mr Ernst and Ms Grimm have no conflicts of interest to declare. |
Vol 72 - N° 1
P. 175-180 - janvier 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?